English
АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ: КАРТА ДИАГНОСТИКИ И СТАНДАРТНАЯ ПОШАГОВАЯ ФАРМАКОТЕРАПИЯ
DOI: https://dx.doi.org/10.18565/therapy.2024.9suppl.36-63
Базовая структура инфографики соответствует следующим источникам:
Клинические рекомендации. Артериальная гипертензия у взрослых. Российское кардиологическое общество. Рубрикатор клинических рекомендаций Минздрава России.
- ID: 62_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/62_3
Адаптировано и переработано со ссылками на использованную литературу
Для цитирования: Артериальная гипертензия: карта диагностики и стандартная пошаговая фармакотерапия.
Алгоритмы диагностики и лечения. Терапия. 2024; 10(9S); 36–63.
Doi: https://dx.doi.org/10.18565/therapy.2024.9suppl.36-63
Литература
1. Клинические рекомендации. Артериальная гипертензия у взрослых. Российское кардиологиче- ское общество. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 62_3. Доступ: https://cr.minzdrav.gov.ru/view-cr/62_3 (дата обращения – 05.10.2024).
2. Whelton P.K., Carey R.M., Aronow W.S. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/ American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018; 71(6): e13–e115. https://doi.org/10.1161/HYP.0000000000000065. PMID: 29133356.
3. Государственный реестр лекарственных средств Минздрава России. Доступ: http://grls. rosminzdrav.ru (дата обращения – 01.09.2024).
4. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – overview and meta-analyses. J Hypertens. 2015; 33(2): 195–211. https://doi.org/10.1097/HJH.0000000000000447. PMID: 25485720.
5. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses. J Hypertens. 2015; 33(7): 1321–41. https://doi.org/10.1097/HJH.0000000000000614. PMID: 26039526.
6. Corrao G., Zambon A., Parodi A. et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: A population-based study in Italy. J Hypertens. 2008; 26(4): 819–24. https://doi.org/10.1097/HJH.0b013e3282f4edd7. PMID: 18327094.
7. Brown M.J., Williams B., Morant S.V. et al.; British Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy (PATHWAY) Studies Group. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydro- chlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): A parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol. 2016; 4(2): 136–47. https://doi.org/10.1016/S2213-8587(15)00377-0. PMID: 26489809. PMCID: PMC4728199.
8. Котовская Ю.В. Пожилой пациент с артериальной гипертонией: фокус на индивидуализацию терапии. Терапия. 2022; 8(9): 145–151.
9. Thomopoulos C., Parati G., Zanchetti A. Effects of blood-pressure-lowering treatment in hypertension: Discontinuations for adverse events attributed to different classes of antihypertensive drugs: Meta- analyses of randomized trials. J Hypertens. 2016; 34(10): 1921–32. https://doi.org/10.1097/HJH.0000000000001052. PMID: 27454050.
10. Kronish I.M., Woodward M., Sergie Z. et al. Meta-analysis: Impact of drug class on adherence to antihypertensives. Circulation. 2011; 123(15): 1611–21. https://doi.org/10.1161/CIRCULATIONAHA.110.983874. PMID: 21464050. PMCID: PMC3084582.
11. Ettehad D., Emdin C.A., Kiran A. et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016; 387(10022): 957–67. https://doi.org/10.1016/S0140-6736(15)01225-8. PMID: 26724178.
12. Webb A.J., Fischer U., Mehta Z., Rothwell P.M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet. 2010; 375(9718): 906–15. https://doi.org/10.1016/S0140-6736(10)60235-8. PMID: 20226989.
13. Wald D.S., Law M., Morris J.K. et al. Combination therapy vs. monotherapy in reducing blood pressure: Meta-analysis on 11 000 participants from 42 trials. Am J Med. 2009; 122(3): 290–300. https://doi.org/10.1016/j.amjmed.2008.09.038. PMID: 19272490.
14. Gupta P., Patel P., Strauch B. et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017; 70(5): 1042–48. https://doi.org/10.1161/HYPERTENSIONAHA.117.09631. PMID: 28847892. PMCID: PMC5642335.
15. Williams B., Mancia G., Spiering W. et al.; Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36(10): 1953–2041. https://doi.org/10.1097/HJH.0000000000001940. PMID: 30234752.
